Franklin Biotechnology Discovery Fund is an active equity fund from Franklin Templeton, ISIN LU0109394709.
Active
Equity
United States
Fund size (GBP) £1.6B
To seek long-term investment growth, through growth of capital. The Fund mainly invests in equities of biotechnology companies and discovery research firms of any market capitalisation. This may include companies involved with genomics, genetic engineering and gene therapy as well as companies involved in the application and development of biotechnology in areas such as health care, pharmaceuticals, and agriculture. These investments may be from anywhere in the world, although the Fund may invest significantly in the US.
How the fund has returned, and where it ranks among peers. Returns to Sep 2026 end, GBP net total return.
+42.7%Q1
1 year return
+86.5%Q1
3 year return
+112.2%Q1
5 year return
Chart type
Compare with
Show
Daily NAV, percent change from the start of the range. Source: FE fundinfo.
1 month−5.7%
3 months−4.9%
Volatility, 3 years16.3%
Ongoing charge (OCF)
Fund size (GBP)£1.6B
What the fund holds
Where the money is: sectors, countries and largest holdings. As supplied by FE fundinfo, last updated 6 Oct 2026. Swipe or use the arrows for more panels.
By sector
Spot concentrations at a glance. Share of the fund's portfolio, as supplied by FE fundinfo, last updated 6 Oct 2026.
Biotechnology76.9%
Pharmaceuticals17.4%
Health Care Services2.8%
See all sectorsA free account shows the full list.
By country
Spot concentrations at a glance. Share of the fund's portfolio, as supplied by FE fundinfo, last updated 6 Oct 2026.
United States80.9%
Netherlands4.6%
United Kingdom2.8%
See all countriesA free account shows the full list.
By asset class
Spot concentrations at a glance. Share of the fund's portfolio, as supplied by FE fundinfo, last updated 6 Oct 2026.
US Equities82.5%
Dutch Equities4.7%
Danish Equities2.9%
See all asset classesA free account shows the full list.
Largest holdings
The biggest positions, and how concentrated the fund is. As supplied by FE fundinfo, last updated 6 Oct 2026.
1. JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY5.0%
2. AMGEN INC.4.7%
3. GILEAD SCIENCES, INC.4.1%
4. ARGENX SE3.9%
5. VERTEX PHARMACEUTICALS INCORPORATED3.8%
See all holdingsA free account shows the full list.
Macro events and this fund
Recent events linked to this fund by its country and sector exposure, and how it moved after. A measured move, not a cause.
Performance, risk and facts
Judge return, risk and cost before a client conversation. Relative return uses the chart's time range. Facts as reported by the manager.
Against its benchmark
How the fund compares with its benchmark over the same period.
Risk
How bumpy the ride has been, plus the regulatory risk rating.
Volatility, 3 years16.3%
Scale 0 to 40%
Sharpe ratio, 3 years (FE)1.16
Scale −1 to 3
Largest fall from a peak (maximum drawdown), 3 years
−30.5%
Volatility and maximum drawdown: calculated by Funds Benchmark, as at 30 Sep 2026.
Sharpe, alpha, beta: FE fundinfo, as at 6 Jul 2026.
Regulatory risk rating (SRRI)5 of 7
Fund facts
Legal and cost facts for a client note. As reported by the manager.
ISIN
LU0109394709
Fund manager
Xiang, McCulloch, Von Emster, Banks, Lee, Lam, Felt, Kornfeld
Management company
Franklin Templeton International Services S.à r.l.
Depositary
Franklin Templeton International Services S.à r.l.
Benchmark
NASDAQ Biotechnology Index
Ongoing charge
Share class launch date
3 Apr 2000
Domicile
LU
Fund type
open-ended fund
SRRI
5 of 7
What a sum would have become
What an amount would have grown to over the period.
n/a
Past performance is not a reliable guide to future returns. Capital is at risk. Source: FE fundinfo. Returns are GBP net total return to month end unless stated. Headline returns to Sep 2026. Fund size is shown in GBP.
Choose which cookies we may use. Essential cookies are always on because the site needs them to work. Analytics cookies are off until you turn them on. Cookieless page-view signals to Google Analytics are sent before you choose and if you reject; they set no cookies. Read the privacy notice
EssentialKeeps you signed in, remembers this choice, your light or dark setting and how many funds you have viewed today. Always on.
AnalyticsMeasurement cookies that show us which pages and tools are used and where visitors come from. Covers Google Analytics, our own visit tracking and short-lived cookies that record where a visit started and which prompt led to a sign-up. Off until you turn it on.
Funds Benchmark